Literature DB >> 14662850

Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.

Amy J Reed1, Hooman Noorchashm, Susan Y Rostami, Yasaman Zarrabi, Alison R Perate, Arjun N Jeganathan, Andrew J Caton, Ali Naji.   

Abstract

Activation of alloreactive CD4 T cells occurs via the direct and indirect pathways of alloantigen presentation. A novel TCR/alloantigen transgenic system was designed that permitted in vivo visualization of CD4 T cell priming through these pathways. When both pathways of alloantigen presentation were intact, CD4 T cell activation in response to cardiac allografts was rapid and systemic by day 4 after transplantation, in contrast to that seen in response to skin allografts, which was delayed until 10-12 days after transplantation. Despite this systemic CD4 T cell activation in response to cardiac allografts, there was a paucity of activated graft-infiltrating CD4 T cells at 4 days posttransplantation. This finding suggests that the initial priming of alloimmune CD4 T cell responses occurs within draining lymphoid organs. Furthermore, alloantigens derived from cardiac allografts failed to promote thymic negative selection of developing thymocytes expressing the alloreactive TCR clonotype. In the absence of a functional direct pathway, the kinetics of activation, anatomic localization, and effector function of alloreactive CD4 T cells remained unchanged. Overall, the present study defines the anatomic and temporal characteristics of CD4 T cell alloimmune responses and demonstrates that CD4 T cell priming via the indirect pathway proceeds optimally in the absence of the direct pathway of alloantigen presentation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662850     DOI: 10.4049/jimmunol.171.12.6502

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Lung function early after lung transplantation is correlated with the frequency of regulatory T cells.

Authors:  Tomoyuki Nakagiri; Gregor Warnecke; Murat Avsar; Stefanie Thissen; Bianca Kruse; Christian Kühn; Petra Ziehme; Ann-Kathrin Knöfel; Nodir Madrahimov; Meinoshin Okumura; Yoshiki Sawa; Jens Gottlieb; André R Simon; Axel Haverich; Martin Strüber
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

2.  Langerhans cells are not required for efficient skin graft rejection.

Authors:  Jagdeep S Obhrai; Martin Oberbarnscheidt; Na Zhang; Daniel L Mueller; Warren D Shlomchik; Fadi G Lakkis; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

3.  Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens.

Authors:  Srdjan M Dragovic; Timothy Hill; Gregory J Christianson; Sungjune Kim; Tim Elliott; Diane Scott; Derry C Roopenian; Luc Van Kaer; Sebastian Joyce
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

4.  The composition of the microbiota modulates allograft rejection.

Authors:  Yuk Man Lei; Luqiu Chen; Ying Wang; Andrew T Stefka; Luciana L Molinero; Betty Theriault; Keston Aquino-Michaels; Ayelet S Sivan; Cathryn R Nagler; Thomas F Gajewski; Anita S Chong; Caroline Bartman; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

5.  Distinct modes of antigen presentation promote the formation, differentiation, and activity of foxp3+ regulatory T cells in vivo.

Authors:  Katherine A Weissler; Victoria Garcia; Elizabeth Kropf; Malinda Aitken; Felipe Bedoya; Amaya I Wolf; Jan Erikson; Andrew J Caton
Journal:  J Immunol       Date:  2015-03-16       Impact factor: 5.422

Review 6.  Immunotherapy with myeloid cells for tolerance induction.

Authors:  Mercedes Rodriguez-García; Peter Boros; Jonathan S Bromberg; Jordi C Ochando
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

7.  ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice.

Authors:  Brian D Hondowicz; Amrita O Batheja; Michele H Metzgar; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2009-12-22       Impact factor: 7.094

8.  Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis.

Authors:  Soyoung Oh; Malinda Aitken; Donald M Simons; Alissa Basehoar; Victoria Garcia; Elizabeth Kropf; Andrew J Caton
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

9.  Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.

Authors:  Charles T Spencer; Srdjan M Dragovic; Stephanie B Conant; Jennifer J Gray; Mu Zheng; Parimal Samir; Xinnan Niu; Magdalini Moutaftsi; Luc Van Kaer; Alessandro Sette; Andrew J Link; Sebastian Joyce
Journal:  Eur J Immunol       Date:  2013-03-05       Impact factor: 5.532

10.  Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells.

Authors:  L L Molinero; P Zhou; Y Wang; H Harlin; B Kee; C Abraham; M L Alegre
Journal:  Am J Transplant       Date:  2007-11-16       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.